Browse studies

Find your next paid study

3,220 recruiting studies matching your filters

RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3

Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24…

MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of ArizonaNCT06814496

Observational

Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population

The purpose of the study is to assess vascular function in African Americans, Hispanic and Caucasian Americans to better understand racial differences in cardi…

Healthy Adults

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Texas at AustinNCT05188079

Phase 2

A Randomized Trial of Steroid Avoidance, Dexamethasone, and RAGE Inhibition for Perioperative Cerebral Edema Management in High-Grade Gliomas

The purpose of this study is to learn whether two alternatives to standard steroid treatment can safely control swelling around a brain tumor after surgery. Th…

High-grade Gliomas (HGG)

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Akshitkumar MIstryNCT07694089

Quality Improvement Study of a New Generation of Whole Body PET Scanners

The researchers are doing this study to test the capabilities of a new total-body PET scanner called the Biograph Vision Quadra. The researchers want to learn …

Non Small Cell Lung Carcinoma NSCLCHead and Neck CancerProstate Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07690917

Phase 1

A Phase 1/2 Study to Evaluate Safety, PK and Biodistribution of an Imaging Agent, 18F-OP-801, After Intravenous Administration to Patients With ALS, Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease and Healthy Volunteers

This is a Phase 1/2 study to evaluate the safety and tolerability of 18F-OP-801 in subjects with ALS, AD, MS, PD and age-matched HVs. 18F-OP-801 is intended as…

Amyotrophic Lateral Sclerosis (ALS)Parkinson Disease (PD)Alzheimer Disease (AD)+1 more

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Ashvattha Therapeutics, Inc.NCT05395624

Phase 2

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy (PSI-Immune)

The study will evaluate patient and Health Care Professional- reported preference for Subcutaneous (SC) compared with IV nivolumab administration or similarly …

Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Diwakar DavarNCT07223424

Observational

Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine

The purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation…

Resistant MigraineChronic Migraine HeadacheHeadache (Migraine)+1 more

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Salvia BioElectronicsNCT07719608

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

The purpose of this study is to identify and confirm new blood and tissue markers for prognosis and tumor hypoxia. Tumor hypoxia, or the condition of low oxyge…

Head and Neck CancerLung CancerLip Cancer+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT00568490

Phase 1

Administration of T Cells Expressing Chondroitin-Sulfate-Proteoglycan-4 Specific Chimeric Antigen Receptors (CAR) in Subjects With Head and Neck Squamous Cell Carcinoma (HNSCC)

The purpose of this study is to test the safety and tolerability of using a new treatment called autologous T lymphocyte chimeric antigen receptor cells agains…

Head and Neck CancerRelapseRecurrent+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

UNC Lineberger Comprehensive Cancer CenterNCT06096038

Phase 2

A Phase 2 Study Assessing Utility of ctDNA in Early Switch of First-line Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

The purpose of this study is to understand whether a blood-based test called circulating tumor DNA (ctDNA) can detect whether participants are having a desired…

Metastatic Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of MiamiNCT07096362

Phase 2

Total Neoadjuvant NALIRIFOX Plus Ablative Dose Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

The researchers are doing this study to find out whether using the chemotherapy regimen NALIRIFOX in combination with ablative dose radiation therapy (AD-XRT) …

Pancreatic Ductal Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT05851924

Phase 2

Phase 2 Trial of 5-Fluorouracil, Oxaliplatin and Liposomal Irinotecan and Immunotherapy (Plus Trastuzumab for HER2-positive Disease) During 1st Line Treatment of Advanced Esophageal and Gastric Adenocarcinoma

This is an open label, phase II, multi-site trial evaluating the efficacy and safety of the combination of 5-FU, oxaliplatin, nal-IRI, and immunotherapy (plus …

Esophageal AdenocarcinomaGastric Adenocarcinoma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Wisconsin, MadisonNCT04150640